LIGHTSITE IIIB Photobiomodulation

· LumiThera, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LIGHTSITE IIIB Photobiomodulation, covering 2024-07-03 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB) [Phase 2, Phase 3]